Detalhe da pesquisa
1.
Efficacy and safety of once-monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo-controlled, 16-week randomized dose-finding study.
Diabetes Obes Metab
; 22(7): 1176-1186, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32128957
2.
Pharmacokinetic and dose-finding studies on efpeglenatide in patients with type 2 diabetes.
Diabetes Obes Metab
; 22(8): 1292-1301, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32175655
3.
Predictive factors associated with three years of response to HbA1c goals with exenatide QW or insulin glargine: Post-hoc analysis of the DURATION-3 study.
Diabetes Obes Metab
; 21(4): 1049-1053, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30520252
4.
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study.
Diabetes Obes Metab
; 21(11): 2429-2439, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31264757
5.
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial.
Lancet
; 379(9833): 2270-8, 2012 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22683137
6.
N-2-pyridinylmethyl-N'-arylmethyl-diaminomaleonitriles: new highly selective chromogenic chemodosimeters for copper(II).
Chemistry
; 18(34): 10506-10, 2012 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22807148
7.
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline.
BMJ Open Diabetes Res Care
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042751
8.
Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial.
Lancet
; 375(9733): 2234-43, 2010 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20609969
9.
Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years.
BMC Endocr Disord
; 11: 9, 2011 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-21529363
10.
Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study.
BMJ Open Diabetes Res Care
; 9(1)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172436
11.
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study.
Lancet
; 372(9645): 1240-50, 2008 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-18782641
12.
Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide.
Diabetes Care
; 42(9): 1733-1741, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31320446
13.
Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.
Regul Pept
; 151(1-3): 123-9, 2008 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-18675854
14.
The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial.
Ann Intern Med
; 146(7): 477-85, 2007 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-17404349
15.
Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
Clin Ther
; 29(11): 2333-48, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18158075
16.
Three-year efficacy and safety of exenatide once weekly: A pooled analysis of three trials.
J Diabetes Complications
; 31(9): 1415-1422, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28669463
17.
Early Pharmacodynamic Effects of Exenatide Once Weekly in Type 2 Diabetes Are Independent of Weight Loss: A Pooled Analysis of Patient-level Data.
Clin Ther
; 38(6): 1464-1473, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27126504
18.
Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes.
J Clin Endocrinol Metab
; 90(11): 5991-7, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16144950
19.
Five-year efficacy and safety data of exenatide once weekly: long-term results from the DURATION-1 randomized clinical trial.
Mayo Clin Proc
; 90(3): 356-65, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25744115
20.
Assessment of pancreatic ß-cell function: review of methods and clinical applications.
Curr Diabetes Rev
; 10(1): 2-42, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24524730